President and Chairman of the Board, AGI
Dermatics
Daniel B. Yarosh, Ph.D., is President and Chairman of the Board,
AGI Dermatics, located in Freeport, Long Island, New York. Dr.
Yarosh received his BA degree in Biology from Macalester College,
St. Paul, Minnesota, in 1976, and his Doctorate in Molecular
Biology from the University of Arizona College of Medicine, Tucson,
Arizona, in 1978. He served as a National Science Foundation Fellow
at Brookhaven National Laboratory, Upton, New York, and then a
Staff Fellow and Cancer Expert at the National Cancer Institute of
the National Institutes of Health, Bethesda, Maryland. In 1985, Dr.
Yarosh founded AGI Dermatics, with an emphasis on the commercial
application of DNA repair. He is the inventor of Dimericine® (T4N5
liposome lotion), which is a liposomal DNA repair enzyme for the
prevention of skin cancer. The drug is now being tested in patients
with high skin cancer risk, patients with organ transplants and
those with the genetic disease xeroderma pigmentosum. AGI Dermatics
is also an ingredient supplier to many major worldwide cosmetic and
personal care companies. In 2006 the company launched its own
Remergent® brand of skincare products, including sunscreens and
prescription drugs. Dr. Yarosh is the author of more than 100
scientific papers and two dozen patents, and serves on the Boards
of the Photomedicine Society and the New York Biotechnology
Association. In 2004, the International Union of Photobiology
presented Dr. Yarosh with the Finsen Award, which is granted every
four years at the International Congress for Photobiology for
breakthrough research in the photobiology sciences. His book
The New Science of Perfect Skin, will be published by
Random House in May 2008.
Dr. Yarosh’s advice to students: “Study the subjects you like,
because your job of the future has probably not been invented
yet.”